IMMU-18. HUMANIZED ANTI-CD47 ANTIBODY COMBINED WITH AN AGONIST ANTI-CD40 ANTIBODY IS AN EFFECTIVE TREATMENT FOR DIPG XENOGRAFTS WITH CRANIOSPINAL DISSEMINATION

INTRODUCTION: DIPG is the most common malignant brainstem tumor in children. The resistance of DIPG to standard treatments along with inoperability of this tumor because of the anatomical location leave DIPG patients with dismal prognosis. Multiple studies revealed that DIPG patients have only a few...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Gholamin, Sharareh, Kahn, Suzana, Esparza, Rogelio, Weissman, Irving, Mitra, Siddhartha, Cheshier, Samuel
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2017
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475118/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.128
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料